Brain Tumors Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Tumors, including details on symptoms, benign and malignant tumors, gliomas, screening, treatment.

Volume 2 (2005), Issue 8 (August)

1. Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue.
   J Histochem Cytochem, 53(8): 963-9. [Abstract] [Full-text]
2. Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children.
   Lancet Oncol, 6(8): 573-80. [Abstract] [Full-text]
3. Chaperone proteins and brain tumors: potential targets and possible therapeutics.
   Neuro-oncol, 7(3): 260-78. [Abstract] [Full-text]
4. Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma.
   Neuro-oncol, 7(3): 246-53. [Abstract] [Full-text]
5. Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo.
   Neuro-oncol, 7(3): 236-45. [Abstract] [Full-text]
6. Flavopiridol downregulates hypoxia-mediated hypoxia-inducible factor-1alpha expression in human glioma cells by a proteasome-independent pathway: implications for in vivo therapy.
   Neuro-oncol, 7(3): 225-35. [Abstract] [Full-text]
7. Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model.
   Neuro-oncol, 7(3): 213-24. [Abstract] [Full-text]
8. The NK1 receptor is involved in the antitumoural action of L-733,060 and in the mitogenic action of substance P on neuroblastoma and glioma cell lines.
   Neuropeptides, 39(4): 427-32. [Abstract] [Full-text]
9. Does vasculogenic mimicry exist in astrocytoma?
   J Histochem Cytochem, 53(8): 997-1002. [Abstract] [Full-text]
10. Impaired capacity for upregulation of MHC class II in tumor-associated microglia.
    Glia, 51(4): 279-85. [Abstract] [Full-text]
11. Corticotroph adenoma of the pituitary in a patient with X-linked adrenal hypoplasia congenita due to a novel mutation of the DAX-1 gene.
    Eur J Endocrinol, 153(2): 211-5. [Abstract] [Full-text]
12. Markers of cell proliferation in a GH-producing adenoma of a patient treated with pegvisomant.
    Eur J Endocrinol, 153(2): 203-5. [Abstract] [Full-text]
13. Pegvisomant therapy in pituitary gigantism: successful treatment in a 12-year-old girl.
    Eur J Endocrinol, 153(2): 195-201. [Abstract] [Full-text]
14. Predictors and rates of treatment-resistant tumor growth in acromegaly.
    Eur J Endocrinol, 153(2): 187-93. [Abstract] [Full-text]
15. Brain tumor oncolysis with replication-conditional herpes simplex virus type 1 expressing the prodrug-activating genes, CYP2B1 and secreted human intestinal carboxylesterase, in combination with cyclophosphamide and irinotecan.
    Cancer Res, 65(15): 6850-7. [Abstract] [Full-text]
16. Novel tumor-specific isoforms of BEHAB/brevican identified in human malignant gliomas.
    Cancer Res, 65(15): 6726-33. [Abstract] [Full-text]
17. Instability of mitochondrial DNA and MRI and clinical correlations in malignant gliomas.
    J Neurooncol, 74(1): 87-9. [Abstract] [Full-text]
18. HER1/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiforme.
    J Neurooncol, 74(1): 77-86. [Abstract] [Full-text]
19. Magnetic resonance imaging and biological markers in pituitary adenomas with invasion of the cavernous sinus space.
    J Neurooncol, 74(1): 71-6. [Abstract] [Full-text]
20. Cerebellopontine angle paraganglioma - report of a case and review of literature.
    J Neurooncol, 74(1): 65-9. [Abstract] [Full-text]
21. Gliosarcomas: analysis of 11 cases do two subtypes exist?
    J Neurooncol, 74(1): 59-63. [Abstract] [Full-text]
22. Osseous metastasis of pineoblastoma: a case report and review of the literature.
    J Neurooncol, 74(1): 53-7. [Abstract] [Full-text]
23. Primary neurocytoma of the spinal cord: a case report and review of literature.
    J Neurooncol, 74(1): 47-52. [Abstract] [Full-text]
24. Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells.
    J Neurooncol, 74(1): 31-40. [Abstract] [Full-text]
25. Techniques to assess the proliferative potential of brain tumors.
    J Neurooncol, 74(1): 19-30. [Abstract] [Full-text]
26. An experimental study of dendritic cells-mediated immunotherapy against intracranial gliomas in rats.
    J Neurooncol, 74(1): 9-17. [Abstract] [Full-text]
27. Immunohistochemical study of central neurocytoma, subependymoma, and subependymal giant cell astrocytoma.
    J Neurooncol, 74(1): 1-8. [Abstract] [Full-text]
28. A method for repositioning of stereotactic brain patients with the aid of real-time CT image guidance.
    Phys Med Biol, 50(16): N201-7. [Abstract] [Full-text]
29. Radiosensitization by 6-aminonicotinamide and 2-deoxy-D-glucose in human cancer cells.
    Int J Radiat Biol, 81(5): 397-408. [Abstract] [Full-text]
30. Brain as a paradigm of organ growth: Hedgehog-Gli signaling in neural stem cells and brain tumors.
    J Neurobiol, 64(4): 476-90. [Abstract] [Full-text]
31. Morphing into cancer: the role of developmental signaling pathways in brain tumor formation.
    J Neurobiol, 64(4): 458-75. [Abstract] [Full-text]
32. Ceramide regulation of the tumor suppressor phosphatase PTEN in rafts isolated from neurotumor cell lines.
    J Neurosci Res, 81(4): 541-50. [Abstract] [Full-text]
33. Cytotoxic T cell targeting of TRP-2 sensitizes human malignant glioma to chemotherapy.
    Oncogene, 24(33): 5226-34. [Abstract] [Full-text]
34. Shc3 affects human high-grade astrocytomas survival.
    Oncogene, 24(33): 5198-206. [Abstract] [Full-text]
35. Disseminating anaplastic brainstem oligodendroglioma associated with allelic loss in the tumor suppressor candidate region D19S246 of chromosome 19 mimicking an inflammatory central nervous system disease in a 9-year-old boy.
    Hum Pathol, 36(7): 854-7. [Abstract] [Full-text]
36. Treatment of primary central nervous system lymphoma.
    Hematol Oncol Clin North Am, 19(4): 611-27, v. [Abstract] [Full-text]
37. The prognostic relevance of molecular alterations in glioblastomas for patients age < 50 years.
    Cancer, 104(4): 825-32. [Abstract] [Full-text]
38. Pro-gastrin-releasing peptide as a factor predicting the incidence of brain metastasis in patients with small cell lung carcinoma with limited disease receiving prophylactic cranial irradiation.
    Cancer, 104(4): 811-6. [Abstract] [Full-text]
39. S100beta as a predictor of brain metastases: brain versus cerebrovascular damage.
    Cancer, 104(4): 817-24. [Abstract] [Full-text]
40. Chromosome 22 tiling-path array-CGH analysis identifies germ-line- and tumor-specific aberrations in patients with glioblastoma multiforme.
    Genes Chromosomes Cancer, 44(2): 161-9. [Abstract] [Full-text]
41. Subtype-specific expression and genetic alterations of the chemokinereceptor gene CXCR4 in medulloblastomas.
    Int J Cancer, 117(1): 82-9. [Abstract] [Full-text]
42. Molecular classification of human gliomas using matrix-based comparative genomic hybridization.
    Int J Cancer, 117(1): 95-103. [Abstract] [Full-text]
43. Supratentorial arterial ischemic stroke following cerebellar tumor resection in two children.
    Pediatr Neurosurg, 41(4): 206-11. [Abstract] [Full-text]
44. Incidence of childhood brain tumors in Syria (1993-2002).
    Pediatr Neurosurg, 41(4): 173-7. [Abstract] [Full-text]
45. Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database).
    J Clin Endocrinol Metab, 90(8): 4636-43. [Abstract] [Full-text]
46. Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion.
    J Clin Endocrinol Metab, 90(8): 4483-8. [Abstract] [Full-text]
47. Target delineation in post-operative radiotherapy of brain gliomas: interobserver variability and impact of image registration of MR(pre-operative) images on treatment planning CT scans.
    Radiother Oncol, 75(2): 217-23. [Abstract] [Full-text]
48. Radiotherapy is effective in patients with glioblastoma multiforme with a limited prognosis and in patients above 70 years of age: a retrospective single institution analysis.
    Radiother Oncol, 75(2): 210-6. [Abstract] [Full-text]
49. Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study.
    J Clin Oncol, 23(23): 5294-304. [Abstract] [Full-text]
50. Probing the infiltrating character of brain tumors: inhibition of RhoA/ROK-mediated CD44 cell surface shedding from glioma cells by the green tea catechin EGCg.
    J Neurochem, 94(4): 906-16. [Abstract] [Full-text]
51. Molecular mechanisms in gliomagenesis.
    Adv Cancer Res, 94: 1-27. [Abstract] [Full-text]
52. Application of multichannel near-infrared spectroscopic topography to physiological monitoring of the cortex during cortical mapping: technical case report.
    Surg Neurol, 64(3): 272-5. [Abstract] [Full-text]
53. Role of stereotactic radiosurgery as a primary treatment option in the management of newly diagnosed multiple (3-6) intracranial metastases.
    Surg Neurol, 64(3): 207-12. [Abstract] [Full-text]
54. Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma.
    Cancer Cell, 8(2): 119-30. [Abstract] [Full-text]
55. Isolated central nervous system involvement in adult T-cell lymphoma/leukaemia.
    Br J Haematol, 130(4): 511-5. [Abstract] [Full-text]
56. Identification of oligodendroglioma specific chromosomal copy number changes in the glioblastoma MI-4 cell line by array-CGH and FISH analyses.
    Cancer Genet Cytogenet, 161(2): 140-5. [Abstract] [Full-text]
57. Epidermal growth factor receptor-transfected bone marrow stromal cells exhibit enhanced migratory response and therapeutic potential against murine brain tumors.
    Cancer Gene Ther, 12(9): 757-68. [Abstract] [Full-text]
58. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma.
    J Clin Oncol, 23(24): 5511-9. [Abstract] [Full-text]
59. Profile of daily life in children with brain tumors: an assessment of health-related quality of life.
    J Clin Oncol, 23(24): 5493-500. [Abstract] [Full-text]
60. Toxicity, biodistribution, and convection-enhanced delivery of the boronated porphyrin BOPP in the 9L intracerebral rat glioma model.
    Int J Radiat Oncol Biol Phys, 63(1): 247-52. [Abstract] [Full-text]
61. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.
    Int J Radiat Oncol Biol Phys, 63(1): 64-74. [Abstract] [Full-text]
62. MRI changes due to early-delayed conformal radiotherapy and postsurgical effects in patients with brain tumors.
    Int J Radiat Oncol Biol Phys, 63(1): 56-63. [Abstract] [Full-text]
63. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
    Int J Radiat Oncol Biol Phys, 63(1): 47-55. [Abstract] [Full-text]
64. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.
    Int J Radiat Oncol Biol Phys, 63(1): 37-46. [Abstract] [Full-text]
65. Visualization of the pyramidal tract in glioma surgery by integrating diffusion tensor imaging in functional neuronavigation.
    Zentralbl Neurochir, 66(3): 133-41. [Abstract] [Full-text]
66. The use of neuronavigation in transnasal transsphenoidal pituitary surgery.
    Zentralbl Neurochir, 66(3): 126-32; discussion 132. [Abstract] [Full-text]
67. Importance of diffusion-weighted imaging in the diagnosis of cystic brain tumors and intracerebral abscesses.
    Zentralbl Neurochir, 66(3): 119-25. [Abstract] [Full-text]
68. Screening of TP53 mutations by DHPLC and sequencing in brain tumours from patients with an occupational exposure to pesticides or organic solvents.
    Mutagenesis, 20(5): 365-73. [Abstract] [Full-text]
69. Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells.
    Brain, 128: 2200-11. [Abstract] [Full-text]
70. Immunophenotypic and ultrastructural validation of a new human glioblastoma cell line.
    Cell Mol Neurobiol, 25(5): 929-41. [Abstract] [Full-text]
71. Giant cells: contradiction to two-hit model of tuber formation?
    Cell Mol Neurobiol, 25(5): 795-805. [Abstract] [Full-text]
72. Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumors.
    Proc Natl Acad Sci U S A, 102(35): 12495-500. [Abstract] [Full-text]
73. In situ neuroblastoma: an important concept related to the natural history of neural crest tumors.
    Pediatr Dev Pathol, 8(3): 305-6. [Abstract] [Full-text]

© 2004-2008 Brain Tumors Research Today. All Rights Reserved.